Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Accendra Health (ACH) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Accendra Health (ACH) over the last 17 years, with Q3 2025 value amounting to 8.34%.

  • Accendra Health's EBITDA Margin fell 7400.0% to 8.34% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.67%, marking a year-over-year decrease of 44000.0%. This contributed to the annual value of 1.94% for FY2024, which is 29500.0% down from last year.
  • Accendra Health's EBITDA Margin amounted to 8.34% in Q3 2025, which was down 7400.0% from 1.15% recorded in Q2 2025.
  • In the past 5 years, Accendra Health's EBITDA Margin registered a high of 9.08% during Q3 2024, and its lowest value of 3.01% during Q4 2024.
  • In the last 5 years, Accendra Health's EBITDA Margin had a median value of 2.41% in 2022 and averaged 2.42%.
  • In the last 5 years, Accendra Health's EBITDA Margin soared by 81600bps in 2024 and then plummeted by -85000bps in 2025.
  • Accendra Health's EBITDA Margin (Quarter) stood at 2.51% in 2021, then tumbled by -183bps to 2.1% in 2022, then surged by 208bps to 2.26% in 2023, then plummeted by -233bps to 3.01% in 2024, then soared by 377bps to 8.34% in 2025.
  • Its last three reported values are 8.34% in Q3 2025, 1.15% for Q2 2025, and 0.0% during Q1 2025.